Eli Lilly delivered a stunning performance Wednesday, shattering fourth-quarter projections and unveiling ambitious 2026 targets that signal unstoppable momentum in the weight loss and diabetes medication market. The pharmaceutical powerhouse expects revenue between $80 billion and $83 billion this year, far exceeding Wall Street’s $77.62…
Uber delivered a mixed financial performance in its final quarter of 2025, showcasing robust revenue expansion driven by its food…
Witnessing molten rock burst from Earth’s crust ranks among the most electrifying experiences available to modern adventurers. What once required…
Every four years, living rooms transform into arenas of armchair expertise. Suddenly, everyone has strong opinions about luge aerodynamics and…
Granola bars line convenience store shelves and gym bags everywhere, marketed as healthy fuel for busy lives. Yet beneath their…
Business
Uber delivered a mixed financial performance in its final quarter of 2025, showcasing robust revenue expansion driven by its food delivery operations while facing…
AMD delivered exactly what Wall Street wanted to hear. The chip designer…
Spot gold climbs 6.2% to $4,950 after worst rout in decade, silver…
The pharmaceutical world witnessed a dramatic shakeup as Novo Nordisk experienced a…
Entertainment
Snoop Dogg broke his silence this weekend with a powerful message of solidarity after his family experienced an unimaginable tragedy.…
Health
Eli Lilly delivered a stunning performance Wednesday, shattering fourth-quarter projections and unveiling ambitious 2026 targets that signal unstoppable momentum in the weight loss and diabetes medication…
